Deciphering the role of the ADAM17-dependent secretome in cell signaling

Journal of Proteome Research

Volumn 13, Issue 4, 2014, Pages 2080-2093

  Kawahara, Rebeca ^a   Lima, Renato Niyama ^a   Domingues, Romênia R ^a   Pauletti, Bianca Alves ^a   Meirelles, Gabriela V ^a   Assis, Michelle ^a   Figueira, Ana Carolina Migliorini ^a   Leme, Adriana Franco Paes ^a  

^a BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

Author keywords

ADAM17; label free; migration; proliferation; secretome; signaling; SILAC

Indexed keywords

CADHERIN; CANSTATIN; CERULOPLASMIN; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; CYSTATIN C; EPHRIN RECEPTOR; FIBRILLIN 1; FIBROMODULIN; FIBULIN 5; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; LACTADHERIN; MATRILIN; MIMECAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE CELL ADHESION MOLECULE; OSTEONECTIN; OSTEOPROTEGERIN; PERLECAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSAPOSIN; PROTEIN TYROSINE KINASE; SCLEROPROTEIN; SERINE PROTEINASE INHIBITOR; SYNDECAN 4; TENASCIN; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; ADAM PROTEIN; PROTEOME; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CELL DEATH; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MASS SPECTROMETRY; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEOMICS; SIGNAL TRANSDUCTION; UPREGULATION; ZYMOGRAPHY; ANIMAL; CELL CULTURE; CELL MOTION; GENE INACTIVATION; GENETICS; ISOTOPE LABELING; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS);

ADAM PROTEINS; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; GENE KNOCKOUT TECHNIQUES; ISOTOPE LABELING; MICE; PROTEOME; SIGNAL TRANSDUCTION;

EID: 84898767133     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr401224u     Document Type: Article

References (81)

1. Chang, C.; Werb, Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis Trends Cell Biol. 2001, 11, S37-43
2. Seals, D. F.; Courtneidge, S. A. The ADAMs family of metalloproteases: multidomain proteins with multiple functions Genes Dev. 2003, 17, 7-30
3. Dean, R. A.; Overall, C. M. Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome Mol. Cell. Proteomics. 2007, 6, 611-23
4. Bech-Serra, J. J.; Santiago-Josefat, B.; Esselens, C.; Saftig, P.; Baselga, J.; Arribas, J.; Canals, F. Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis Mol. Cell. Biol. 2006, 26, 5086-95
5. Starr, A. E.; Bellac, C. L.; Dufour, A.; Goebeler, V.; Overall, C. M. Biochemical characterization and N-terminomics analysis of leukolysin, the membrane-type 6 matrix metalloprotease (MMP25): chemokine and vimentin cleavages enhance cell migration and macrophage phagocytic activities J. Biol. Chem. 2012, 287, 13382-95
6. Kuhn, P. H.; Koroniak, K.; Hogl, S.; Colombo, A.; Zeitschel, U.; Willem, M.; Volbracht, C.; Schepers, U.; Imhof, A.; Hoffmeister, A.; Haass, C.; Rossner, S.; Brase, S.; Lichtenthaler, S. F. Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons EMBO J. 2012, 31, 3157-68
7. Prudova, A.; auf dem Keller, U.; Butler, G. S.; Overall, C. M. Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics Mol. Cell. Proteomics 2010, 9, 894-911
8. auf dem Keller, U.; Prudova, A.; Eckhard, U.; Fingleton, B.; Overall, C. M. Systems-level analysis of proteolytic events in increased vascular permeability and complement activation in skin inflammation Sci. Signaling 2013, 6, rs2
9. Jefferson, T.; Auf dem Keller, U.; Bellac, C.; Metz, V. V.; Broder, C.; Hedrich, J.; Ohler, A.; Maier, W.; Magdolen, V.; Sterchi, E.; Bond, J. S.; Jayakumar, A.; Traupe, H.; Chalaris, A.; Rose-John, S.; Pietrzik, C. U.; Postina, R.; Overall, C. M.; Becker-Pauly, C. The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin beta and ADAM10 Cell. Mol. Life Sci. 2013, 70, 309-33
10. Arribas, J.; Esselens, C. ADAM17 as a therapeutic target in multiple diseases Curr. Pharm. Des. 2009, 15, 2319-35
11. Scheller, J.; Chalaris, A.; Garbers, C.; Rose-John, S. ADAM17: a molecular switch to control inflammation and tissue regeneration Trends Immunol. 2011, 32, 380-7
12. Pruessmeyer, J.; Ludwig, A. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer Semin. Cell Dev. Biol. 2009, 20, 164-74
13. van der Vorst, E. P.; Keijbeck, A. A.; de Winther, M. P.; Donners, M. M. A disintegrin and metalloproteases: molecular scissors in angiogenesis, inflammation and atherosclerosis Atherosclerosis 2012, 224, 302-8
14. Blobel, C. P. ADAMs: key components in EGFR signalling and development Nat. Rev. Mol. Cell Biol. 2005, 6, 32-43
15. Franovic, A.; Robert, I.; Smith, K.; Kurban, G.; Pause, A.; Gunaratnam, L.; Lee, S. Multiple acquired renal carcinoma tumor capabilities abolished upon silencing of ADAM17 Cancer Res. 2006, 66, 8083-90
16. Hall, K. C.; Hill, D.; Otero, M.; Plumb, D. A.; Froemel, D.; Dragomir, C. L.; Maretzky, T.; Boskey, A.; Crawford, H. C.; Selleri, L.; Goldring, M. B.; Blobel, C. P. ADAM17 controls endochondral ossification by regulating terminal differentiation of chondrocytes Mol. Cell. Biol. 2013, 33, 3077-90
17. Breshears, L. M.; Schlievert, P. M.; Peterson, M. L. A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1) J. Biol. Chem. 2012, 287, 32578-87
18. Fan, H.; Derynck, R. Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades EMBO J. 1999, 18, 6962-72
19. Garbers, C.; Janner, N.; Chalaris, A.; Moss, M. L.; Floss, D. M.; Meyer, D.; Koch-Nolte, F.; Rose-John, S.; Scheller, J. Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding J. Biol. Chem. 2011, 286, 14804-11
20. Althoff, K.; Reddy, P.; Voltz, N.; Rose-John, S.; Mullberg, J. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins Eur. J. Biochem. 2000, 267, 2624-31
21. Malapeira, J.; Esselens, C.; Bech-Serra, J. J.; Canals, F.; Arribas, J. ADAM17 (TACE) regulates TGFbeta signaling through the cleavage of vasorin Oncogene 2011, 30, 1912-22
22. Gooz, P.; Gooz, M.; Baldys, A.; Hoffman, S. ADAM-17 regulates endothelial cell morphology, proliferation, and in vitro angiogenesis Biochem. Biophys. Res. Commun. 2009, 380, 33-8
23. Das, S.; Czarnek, M.; Bzowska, M.; Mezyk-Kopec, R.; Stalinska, K.; Wyroba, B.; Sroka, J.; Jucha, J.; Deneka, D.; Stoklosa, P.; Ogonek, J.; Swartz, M. A.; Madeja, Z.; Bereta, J. ADAM17 silencing in mouse colon carcinoma cells: the effect on tumoricidal cytokines and angiogenesis PloS One 2012, 7, e50791
24. Saftig, P.; Reiss, K. The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential? Eur. J. Cell Biol. 2011, 90, 527-35
25. Makridakis, M.; Vlahou, A. Secretome proteomics for discovery of cancer biomarkers J. Proteomics 2010, 73, 2291-305
26. Jacobs, J. M.; Waters, K. M.; Kathmann, L. E.; Camp, D. G., 2nd; Wiley, H. S.; Smith, R. D.; Thrall, B. D. The mammary epithelial cell secretome and its regulation by signal transduction pathways J. Proteome Res. 2008, 7, 558-69
27. Karagiannis, G. S.; Pavlou, M. P.; Diamandis, E. P. Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology Mol. Oncol. 2010, 4, 496-510
28. Le Gall, S. M.; Maretzky, T.; Issuree, P. D.; Niu, X. D.; Reiss, K.; Saftig, P.; Khokha, R.; Lundell, D.; Blobel, C. P. ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site J. Cell Sci. 2010, 123, 3913-22
29. Cox, J.; Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification Nat. Biotechnol. 2008, 26, 1367-72
30. Cox, J.; Neuhauser, N.; Michalski, A.; Scheltema, R. A.; Olsen, J. V.; Mann, M. Andromeda: a peptide search engine integrated into the MaxQuant environment J. Proteome Res. 2011, 10, 1794-805
31. Chen, E. Y.; Xu, H.; Gordonov, S.; Lim, M. P.; Perkins, M. H.; Ma'ayan, A. Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers Bioinformatics 2012, 28, 105-11
32. Batista, F. A.; Trivella, D. B.; Bernardes, A.; Gratieri, J.; Oliveira, P. S.; Figueira, A. C.; Webb, P.; Polikarpov, I. Structural insights into human peroxisome proliferator activated receptor delta (PPAR-delta) selective ligand binding PloS One 2012, 7, e33643
33. Paes Leme, A. F.; Kitano, E. S.; Furtado, M. F.; Valente, R. H.; Camargo, A. C.; Ho, P. L.; Fox, J. W.; Serrano, S. M. Analysis of the subproteomes of proteinases and heparin-binding toxins of eight Bothrops venoms Proteomics 2009, 9, 733-45
34. Paes Leme, A. F.; Escalante, T.; Pereira, J. G.; Oliveira, A. K.; Sanchez, E. F.; Gutierrez, J. M.; Serrano, S. M.; Fox, J. W. High resolution analysis of snake venom metalloproteinase (SVMP) peptide bond cleavage specificity using proteome based peptide libraries and mass spectrometry J. Proteomics 2011, 74, 401-10
35. Paes Leme, A. F.; Sherman, N. E.; Smalley, D. M.; Sizukusa, L. O.; Oliveira, A. K.; Menezes, M. C.; Fox, J. W.; Serrano, S. M. Hemorrhagic activity of HF3, a snake venom metalloproteinase: insights from the proteomic analysis of mouse skin and blood plasma J. Proteome Res. 2012, 11, 279-91
36. Colzani, M.; Schutz, F.; Potts, A.; Waridel, P.; Quadroni, M. Relative protein quantification by isobaric SILAC with immonium ion splitting (ISIS) Mol. Cell. Proteomics 2008, 7, 927-37
37. Zhang, G.; Neubert, T. A. Comparison of three quantitative phosphoproteomic strategies to study receptor tyrosine kinase signaling J. Proteome Res. 2011, 10, 5454-62
38. Duffy, M. J.; Mullooly, M.; O'Donovan, N.; Sukor, S.; Crown, J.; Pierce, A.; McGowan, P. M. The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer? Clin. Proteomics 2011, 8, 9
39. Mochizuki, S.; Okada, Y. ADAMs in cancer cell proliferation and progression Cancer Sci. 2007, 98, 621-8
40. Lopez-Otin, C.; Overall, C. M. Protease degradomics: a new challenge for proteomics Nat. Rev. Mol. Cell Biol. 2002, 3, 509-19
41. Schilling, O.; Overall, C. M. Proteomic discovery of protease substrates Curr. Opin. Chem. Biol. 2007, 11, 36-45
42. Dang, M.; Armbruster, N.; Miller, M. A.; Cermeno, E.; Hartmann, M.; Bell, G. W.; Root, D. E.; Lauffenburger, D. A.; Lodish, H. F.; Herrlich, A. Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 9776-81
43. Whiteside, T. L. The tumor microenvironment and its role in promoting tumor growth Oncogene 2008, 27, 5904-12
44. De Boeck, A.; Hendrix, A.; Maynard, D.; Van Bockstal, M.; Daniels, A.; Pauwels, P.; Gespach, C.; Bracke, M.; De Wever, O. Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression Proteomics 2013, 13, 379-88
45. Chen, S. T.; Pan, T. L.; Juan, H. F.; Chen, T. Y.; Lin, Y. S.; Huang, C. M. Breast tumor microenvironment: proteomics highlights the treatments targeting secretome J. Proteome Res. 2008, 7, 1379-87
46. Kessenbrock, K.; Plaks, V.; Werb, Z. Matrix metalloproteinases: regulators of the tumor microenvironment Cell 2010, 141, 52-67
47. Gallagher, P. G.; Bao, Y.; Prorock, A.; Zigrino, P.; Nischt, R.; Politi, V.; Mauch, C.; Dragulev, B.; Fox, J. W. Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for host-tumor interactions in metastasis Cancer Res. 2005, 65, 4134-46
48. McGowan, P. M.; Ryan, B. M.; Hill, A. D.; McDermott, E.; O'Higgins, N.; Duffy, M. J. ADAM-17 expression in breast cancer correlates with variables of tumor progression Clin. Cancer Res. 2007, 13, 2335-43
49. Zheng, X.; Jiang, F.; Katakowski, M.; Zhang, Z. G.; Lu, Q. E.; Chopp, M. ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation Cancer Biol. Ther. 2009, 8, 1045-54
50. Pruessmeyer, J.; Martin, C.; Hess, F. M.; Schwarz, N.; Schmidt, S.; Kogel, T.; Hoettecke, N.; Schmidt, B.; Sechi, A.; Uhlig, S.; Ludwig, A. A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan-1 and -4 by lung epithelial cells J. Biol. Chem. 2010, 285, 555-64
51. Rowlands, D. J.; Islam, M. N.; Das, S. R.; Huertas, A.; Quadri, S. K.; Horiuchi, K.; Inamdar, N.; Emin, M. T.; Lindert, J.; Ten, V. S.; Bhattacharya, S.; Bhattacharya, J. Activation of TNFR1 ectodomain shedding by mitochondrial Ca2+ determines the severity of inflammation in mouse lung microvessels J. Clin. Invest. 2011, 121, 1986-99
52. Stamenkovic, I.; Yu, Q. Shedding light on proteolytic cleavage of CD44: the responsible sheddase and functional significance of shedding J. Invest. Dermatol. 2009, 129, 1321-4
53. Maretzky, T.; Evers, A.; Zhou, W.; Swendeman, S. L.; Wong, P. M.; Rafii, S.; Reiss, K.; Blobel, C. P. Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17 Nat. Commun. 2011, 2, 229
54. Xu, P.; Derynck, R. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation Mol. Cell 2010, 37, 551-66
55. Chen, X.; Chen, L.; Chen, J.; Hu, W.; Gao, H.; Xie, B.; Wang, X.; Yin, Z.; Li, S.; Wang, X. ADAM17 promotes U87 glioblastoma stem cell migration and invasion Brain Res. 2013, 1538, 151-8
56. Zheng, Y.; Xia, Y.; Hawke, D.; Halle, M.; Tremblay, M. L.; Gao, X.; Zhou, X. Z.; Aldape, K.; Cobb, M. H.; Xie, K.; He, J.; Lu, Z. FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST Mol. Cell 2009, 35, 11-25
57. Wang, X.; Oka, T.; Chow, F. L.; Cooper, S. B.; Odenbach, J.; Lopaschuk, G. D.; Kassiri, Z.; Fernandez-Patron, C. Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis Hypertension 2009, 54, 575-82
58. Li, Y. Q.; Yan, J. P.; Xu, W. L.; Wang, H.; Xia, Y. J.; Wang, H. J.; Zhu, Y. Y.; Huang, X. J. ADAM17 mediates MMP9 expression in lung epithelial cells PloS One 2013, 8, e51701
59. Xiao, L. J.; Lin, P.; Lin, F.; Liu, X.; Qin, W.; Zou, H. F.; Guo, L.; Liu, W.; Wang, S. J.; Yu, X. G. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion Int. J. Oncol. 2012, 40, 1714-24
60. Chana, R. S.; Lewington, A. J.; Brunskill, N. J. Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists Kidney Int. 2004, 65, 2081-90
61. Chen, L.; Necela, B. M.; Su, W.; Yanagisawa, M.; Anastasiadis, P. Z.; Fields, A. P.; Thompson, E. A. Peroxisome proliferator-activated receptor gamma promotes epithelial to mesenchymal transformation by Rho GTPase-dependent activation of ERK1/2 J. Biol. Chem. 2006, 281, 24575-87
62. Takahashi, H.; Fujita, K.; Fujisawa, T.; Yonemitsu, K.; Tomimoto, A.; Ikeda, I.; Yoneda, M.; Masuda, T.; Schaefer, K.; Saubermann, L. J.; Shimamura, T.; Saitoh, S.; Tachibana, M.; Wada, K.; Nakagama, H.; Nakajima, A. Inhibition of peroxisome proliferator-activated receptor gamma activity in esophageal carcinoma cells results in a drastic decrease of invasive properties Cancer Sci. 2006, 97, 854-60
63. Iozzo, R. V. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth Crit. Rev. Biochem. Mol. Biol. 1997, 32, 141-74
64. Gu, X. S.; Lei, J. P.; Shi, J. B.; Lian, W. L.; Yang, X.; Zheng, X.; Qin, Y. W. Mimecan is involved in aortic hypertrophy induced by sinoaortic denervation in rats Mol. Cell. Biochem. 2011, 352, 309-16
65. Kampmann, A.; Fernandez, B.; Deindl, E.; Kubin, T.; Pipp, F.; Eitenmuller, I.; Hoefer, I. E.; Schaper, W.; Zimmermann, R. The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis Mol. Cell. Biochem. 2009, 322, 15-23
66. Zoeller, J. J.; Whitelock, J. M.; Iozzo, R. V. Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis Matrix Biol. 2009, 28, 284-91
67. Patel, V. N.; Knox, S. M.; Likar, K. M.; Lathrop, C. A.; Hossain, R.; Eftekhari, S.; Whitelock, J. M.; Elkin, M.; Vlodavsky, I.; Hoffman, M. P. Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis Development 2007, 134, 4177-86
68. Ishijima, M.; Suzuki, N.; Hozumi, K.; Matsunobu, T.; Kosaki, K.; Kaneko, H.; Hassell, J. R.; Arikawa-Hirasawa, E.; Yamada, Y. Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation Matrix Biol. 2012, 31, 234-45
69. Hohenester, E.; Yurchenco, P. D. Laminins in basement membrane assembly Cell Adhes. Migr. 2013, 7, 56-63
70. Barascuk, N.; Vassiliadis, E.; Zheng, Q.; Wang, Y.; Wang, W.; Larsen, L.; Rasmussen, L. M.; Karsdal, M. A. Levels of circulating MMCN-151, a degradation product of mimecan, reflect pathological extracellular matrix remodeling in apolipoprotein E knockout mice Biomarker Insights 2011, 6, 97-106
71. Whitelock, J. M.; Murdoch, A. D.; Iozzo, R. V.; Underwood, P. A. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases J. Biol. Chem. 1996, 271, 10079-86
72. Caescu, C. I.; Jeschke, G. R.; Turk, B. E. Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10 Biochem. J. 2009, 424, 79-88
73. Peschon, J. J.; Slack, J. L.; Reddy, P.; Stocking, K. L.; Sunnarborg, S. W.; Lee, D. C.; Russell, W. E.; Castner, B. J.; Johnson, R. S.; Fitzner, J. N.; Boyce, R. W.; Nelson, N.; Kozlosky, C. J.; Wolfson, M. F.; Rauch, C. T.; Cerretti, D. P.; Paxton, R. J.; March, C. J.; Black, R. A. An essential role for ectodomain shedding in mammalian development Science 1998, 282, 1281-4
74. Reddy, P.; Slack, J. L.; Davis, R.; Cerretti, D. P.; Kozlosky, C. J.; Blanton, R. A.; Shows, D.; Peschon, J. J.; Black, R. A. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme J. Biol. Chem. 2000, 275, 14608-14
75. Kalus, I.; Bormann, U.; Mzoughi, M.; Schachner, M.; Kleene, R. Proteolytic cleavage of the neural cell adhesion molecule by ADAM17/TACE is involved in neurite outgrowth J. Neurochem. 2006, 98, 78-88
76. Ruhe, J. E.; Streit, S.; Hart, S.; Ullrich, A. EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing Cell. Signalling 2006, 18, 1515-27
77. Rovida, E.; Paccagnini, A.; Del Rosso, M.; Peschon, J.; Dello Sbarba, P. TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation J. Immunol. 2001, 166, 1583-9
78. Guo, L.; Eisenman, J. R.; Mahimkar, R. M.; Peschon, J. J.; Paxton, R. J.; Black, R. A.; Johnson, R. S. A proteomic approach for the identification of cell-surface proteins shed by metalloproteases Mol. Cell. Proteomics 2002, 1, 30-6
79. Weskamp, G.; Mendelson, K.; Swendeman, S.; Le Gall, S.; Ma, Y.; Lyman, S.; Hinoki, A.; Eguchi, S.; Guaiquil, V.; Horiuchi, K.; Blobel, C. P. Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes Circ. Res. 2010, 106, 932-40
80. Garton, K. J.; Gough, P. J.; Philalay, J.; Wille, P. T.; Blobel, C. P.; Whitehead, R. H.; Dempsey, P. J.; Raines, E. W. Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17) J. Biol. Chem. 2003, 278, 37459-64
81. Stoeck, A.; Keller, S.; Riedle, S.; Sanderson, M. P.; Runz, S.; Le Naour, F.; Gutwein, P.; Ludwig, A.; Rubinstein, E.; Altevogt, P. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44 Biochem. J. 2006, 393, 609-18 e Tecnológico e Tecnológico e Tecnológico